SANTA CLARA, Calif., Jan. 12 /PRNewswire/ -- Finesse, a manufacturer of measurement and control solutions for life science applications, announced today that it has joined the HART Communication Foundation, in order to pursue an active role in the application of HART technology to the life science industry.
"The ability of HART enabled devices to introduce predictive sensor diagnostics on critical measurements such as pH and Dissolved Oxygen can provide the life science industry with vastly improved process quality and reliability," said Larry West, Executive V.P. Sales at Finesse. "While we will continue to support the specialized role of bus technologies such as Foundation fieldbus, we have found that the ease of use, reduced cost, backwards compatibility, and reliable performance of HART render it an ideal solution for the life science industry," added West.
About the HART Communication Foundation
The HART Communication Foundation is an independent, not-for-profit organization providing worldwide support for application of the HART Protocol. Established in 1993, the Foundation is the technology owner and standards setting body for the HART Protocol.
The Foundation manages the Protocol standards, ensures the technology is openly available for the benefit of the industry and educates users by providing vendor-neutral training and support for application of the HART Protocol.
California based Finesse is a global leader in process measurement and control technologies. Our family of products -- TruBio(R), TruLogic(R), TruViu(R), TruCell(R), TrupH(R) and TruDO(R) provide comprehensive solutions for measurement and control processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.